Gunther Birznieks

2018

In 2018, Gunther Birznieks earned a total compensation of $2M as Senior Vice President, Business Development at Vanda Pharmaceuticals, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$187,500
Option Awards$805,077
Salary$375,000
Stock Awards$618,600
Other$16,803
Total$2,002,980

Birznieks received $805.1K in option awards, accounting for 40% of the total pay in 2018.

Birznieks also received $187.5K in non-equity incentive plan, $375K in salary, $618.6K in stock awards and $16.8K in other compensation.

Rankings

In 2018, Gunther Birznieks' compensation ranked 5,741st out of 14,244 executives tracked by ExecPay. In other words, Birznieks earned more than 59.7% of executives.

ClassificationRankingPercentile
All
5,741
out of 14,244
60th
Division
Manufacturing
2,174
out of 5,759
62nd
Major group
Chemicals And Allied Products
805
out of 2,122
62nd
Industry group
Drugs
672
out of 1,811
63rd
Industry
Pharmaceutical Preparations
520
out of 1,385
63rd
Source: SEC filing on April 25, 2019.

Birznieks' colleagues

We found four more compensation records of executives who worked with Gunther Birznieks at Vanda Pharmaceuticals in 2018.

2018

Mihael Polymeropoulos

Vanda Pharmaceuticals

Chief Executive Officer

2018

Timothy Williams

Vanda Pharmaceuticals

General Counsel

2018

Gian Reverberi

Vanda Pharmaceuticals

Senior Vice President, Chief Commercial Officer

2018

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

News

You may also like